HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ciglitazone

structure given in second source; PPAR agonist used for type II diabetes
Also Known As:
5-(4-(1-methylcyclohexylmethoxy)benzyl)thiazolidine-2,4-dione; ADD 3878; ADD-3878; ciglitizone
Networked: 168 relevant articles (8 outcomes, 38 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Chen, Fei: 5 articles (01/2006 - 11/2003)
2. Harrison, Lawrence E: 5 articles (01/2006 - 11/2003)
3. Chen, Ching-Shih: 4 articles (03/2010 - 04/2005)
4. Kulp, Samuel K: 4 articles (03/2010 - 04/2005)
5. Hake, Paul W: 4 articles (01/2010 - 12/2003)
6. Zingarelli, Basilia: 4 articles (01/2010 - 12/2003)
7. Hong, Sung Hee: 3 articles (10/2020 - 01/2011)
8. Boisbrun, Michel: 3 articles (11/2014 - 12/2008)
9. Grillier-Vuissoz, Isabelle: 3 articles (11/2014 - 12/2008)
10. Mazerbourg, Sabine: 3 articles (11/2014 - 12/2008)

Related Diseases

1. Insulin Resistance
2. Inflammation (Inflammations)
3. Diabetic Nephropathies (Diabetic Nephropathy)
4. Pneumonia (Pneumonitis)
5. Hemorrhagic Shock

Related Drugs and Biologics

1. PPAR gamma
2. Insulin (Novolin)
3. Hypoglycemic Agents (Hypoglycemics)
4. NF-kappa B (NF-kB)
5. Blood Glucose (Blood Sugar)
6. Protein Kinases (Protein Kinase)
7. Triglycerides (Triacylglycerol)
8. Thromboxane A2 (A2, Thromboxane)
9. Homocysteine
10. Glycerol (Glycerine)

Related Therapies and Procedures

1. Oral Administration
2. Aftercare (After-Treatment)
3. Resuscitation
4. Therapeutics
5. Intranasal Administration